Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aixa E. Soyano-Muller
Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
Adjuvant Treatment of HER2-positive Breast Cancer: Winning Efforts Continue to Improve HER2-positive Patient Outcome Long-Term
Breast Cancer Research
Cancer Research
Oncology
New Developments in the Treatment of HER2-positive Breast Cancer
Breast Cancer: Targets and Therapy
Oncology
Octreotide LAR and Tamoxifen Versus Tamoxifen in Phase III Randomize Early Breast Cancer Trials: NCIC CTG MA.14 and NSABP B-29
Breast Cancer Research and Treatment
Cancer Research
Oncology
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Current Approaches and Future Directions in the Treatment of HER2-positive Breast Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival
British Journal of Cancer
Cancer Research
Oncology
Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! For Women With Node-Negative, ER-positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Breast Cancer Research and Treatment
Cancer Research
Oncology
